Targeting Neurotrophic/Growth Factor Expression and Signaling for Antidepressant Drug Development

E-ISSN： 1996-3181|6|2|151-160

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.6, Iss.2, 2007-04, pp. : 151-160

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Brain-Derived Neurotrophic Factor and Antidepressant Activity

Current Pharmaceutical Design, Vol. 11, Iss. 12, 2005-05 ,pp. : 1495-1510

Bentham Science Publishers

Access to resources Recommend Favorite

Cross Talk between the Cardiovascular and Nervous Systems:Neurotrophic Effects of Vascular Endothelial Growth Factor (VEGF) and Angiogenic Effects of Nerve Growth Factor (NGF)-Implications in Drug Development

Current Pharmaceutical Design, Vol. 12, Iss. 21, 2006-07 ,pp. : 2609-2622

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy

By Heinzle Christine Sutterlüüty Hedwig Grusch Michael Grasl-Kraupp Bettina Berger Walter Marian Brigitte

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 7, 2011-07 ,pp. : 829-846

Informa Healthcare

Access to resources Recommend Favorite

Advances in Targeting Insulin-like Growth Factor Signaling Pathway in Cancer Treatment

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2899-2911

Bentham Science Publishers

Access to resources Recommend Favorite

Neurotrophic effects of antidepressant drugs

By Castren E.

Current Opinion in Pharmacology, Vol. 4, Iss. 1, 2004-02 ,pp. : 58-64

Elsevier

Access to resources Recommend Favorite